Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Workingnews2026-09-30T17:48:55+00:00September 30th, 2026|The New York Times|
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugsnews2026-08-31T16:43:57+00:00August 31st, 2026|The New York Times|
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Manynews2026-08-27T09:02:45+00:00August 27th, 2026|The New York Times|
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancernews2026-08-26T16:54:01+00:00August 26th, 2026|The New York Times|
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthroughnews2026-05-12T14:34:01+00:00May 12th, 2026|The New York Times|
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancernews2026-05-01T21:28:23+00:00May 1st, 2026|The New York Times|
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancernews2026-04-22T03:48:00+00:00April 22nd, 2026|The New York Times|
Blood Filtration Offers Hope in the Fight Against Pancreatic Cancernews2024-07-18T17:44:22+00:00July 18th, 2024|Medical Device News Magazine|
